Delivery Order SPE2DE21D7020-SPE2D625F3XDF
- Not listed
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $55,947.15 by the Defense Health Agency's Medical Supply Chain on July 29, 2025, with an ultimate completion date of August 5, 2025. The contract, which carries no set-aside designation, calls for the delivery of Ranger Global DCB (drug-coated balloon) devices measuring 4.0 x 120mm with a 150cm length. Performance will take place at Boston...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order contract valued at $1,974.29 by the Defense Health Agency's Medical Supply Chain on July 2, 2025, with an ultimate completion date of July 10, 2025. The contract, issued without a set-aside designation, covers the procurement of a Ranger Global DCB (drug-coated balloon) OTW (over-the-wire) 7.0 x 60mm 80cm medical device. The contract employs fixed-price...
- Boston Scientific Corp has been awarded a delivery order valued at $2,981.31 for RANGER GLOBAL DCB (drug-coated balloon) 7.0 x 150mm devices, 150cm in length, under a fixed price contract with economic price adjustment provisions. The award, issued on June 18, 2025, with an ultimate completion date of June 26, 2025, is funded through the Defense Health Agency's Medical Supply Chain and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. This delivery order was not...
- Boston Scientific Corp was awarded a $26,303.48 fixed-price delivery order with economic price adjustment by the Defense Health Agency's Medical Supply Chain on June 10, 2025, for the supply of Ranger Global DCB (Drug-Coated Balloon) orthopedic/thoracic wound care products (7.0 x 200mm, 150cm). The contract is not set-aside and calls for completion by June 17, 2025, with performance taking place at Boston Scientific's facility in Marlborough, Massachusetts. This delivery order represents a...
- This is a $43,399.46 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts. The contract is for the delivery of RANGER GLOBAL DCB OTW 5.0 X 200MM 150CM medical devices, which are drug-coated balloons used for cardiovascular procedures. This contract is not set aside and is part of Boston Scientific's broader portfolio of federal contracts with agencies like the...
- The Defense Health Agency's Medical Supply Chain has awarded a delivery order to Boston Scientific Corp for agent drug-coated balloons, with a ceiling value of approximately $19.9K and an ultimate completion date of September 22, 2025. This fixed-price contract with economic price adjustment provisions was awarded on September 15, 2025, with no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at Boston Scientific's...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $8,714.55 to Boston Scientific Corp for drug-coated balloons, with performance scheduled to conclude by July 25, 2025. This fixed-price delivery order with economic price adjustment represents a competitive contract with no set-aside designation. Boston Scientific, headquartered in Marlborough, Massachusetts, will perform work at its primary facility in the same location. The contract exemplifies the ongoing...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $18,134.55 for agent drug-coated balloons by the Defense Health Agency's Medical Supply Chain on August 8, 2025. The delivery order, which carries an ultimate completion date of August 15, 2025, represents a competitive award with no set-aside designation. The contract employs fixed-price pricing with economic price adjustment mechanisms...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $26,532.60 to Boston Scientific Corp for agent drug-coated balloon medical devices. The contract, issued on August 18, 2025, carries a fixed-price pricing structure with economic price adjustment provisions and has an ultimate completion date of August 25, 2025. This delivery order represents a continuation of Boston Scientific's role as a key supplier of specialized cardiovascular intervention equipment to...
- The U.S. Department of Defense's Medical Supply Chain awarded a fixed-price delivery order valued at $17,802.20 to Boston Scientific Corp for agent drug-coated balloons. Issued on September 10, 2025, with an ultimate completion date of September 17, 2025, this delivery order represents a competitive award with no set-aside designation. The contract will be performed at Boston Scientific's facility in Marlborough, Massachusetts, where the company manufactures and distributes the specialized...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F3XDFDelivery Order
The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $5,710.95 to Boston Scientific Corp for Ranger Global drug-coated balloon (DCB) devices measuring 5.0 x 200mm with a 90cm length. This fixed-price contract with economic price adjustment provisions was awarded on September 19, 2025, with an ultimate completion date of September 26, 2025. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts, and no small business set-aside was utilized for this award. The delivery order represents a discrete task under a larger indefinite delivery vehicle arrangement, enabling the Defense Health Agency to procure specialized cardiovascular intervention equipment as needed. Boston Scientific Corp, a globally recognized medical technology company specializing in advanced cardiovascular and interventional medical devices, continues to serve as a key federal healthcare supplier through its extensive portfolio of federal contracts. The company maintains multiple indefinite delivery agreements with the Defense Health Agency and Veterans Health Administration, positioning it as a critical provider of implantable devices, stents, catheters, and other specialized medical technologies to military and veteran healthcare systems. This particular delivery order for drug-coated balloons aligns with Boston Scientific's established role in supplying cardiovascular intervention tools that support minimally invasive treatment options across the federal healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 9/19/25 |